7 Asthma, Part 2 Flashcards
pathophysiologic hallmark of asthma
a reduction in airway diameter caused by
1) smooth muscle contraction,
2) vascular congestion,
3) bronchial wall edema, and
4) thick secretions
most common acute asthma stimulus
viral acute respiratory infections
best predictor of hospitalization in patients with acute asthma
Comparing measures of FEV1 or PEFR at ED presentation and 1 hour after treatment
important asthma mimickers
Acute heart failure (“cardiac asthma”)
Upper arway obstruction
PE
Aspiration of foreign body or gastric acid
Tumors/disorders causing endobronchial obstruction
Interstitial lung disease
Vocal cord dysfunction
most common side effect of beta adrenergic drugs
skeletal muscle tremor
patients may also experience anxiety, headache, hyperglycemia, tachycardia/hypertension
Clinical toxicity is rare and less common than undertreatment complications
remarks on MDI
A spacing device attached to the inhaler improves drug disposition; when optimally used, metered-dose inhaler therapy delivers the most drug to target airways, better than nebulized therapy
remarks on corticosteroids in asthma
produce beneficial effects by restoring B-adrenergic responsiveness and reducing inflammation
used in all but mild, easily fully reversed episodes of acute asthma
Corticosteroids given within 1 hour of arrival in the ED reduce the need for hospitalization
the peak anti-inflammatory effect occurs at least _______ after IV or PO corticosteroid administration
4-8 hours
an initial corticosteroid dose of _______ is sufficient
PO prednisone of 40-60 mg
or
IV methylprednisolone of 1mg/kg
[or IV hydrocortisone 5 mg/kg?]
In asthma, give patients who are being discharged home after ED treatment a:
5-10 day nontapering course of prednisone (40-60 mg/day in a single daily dose or its equivalent)
or a 2-day course of oral dexamethasone (16 mg/day in a single daily dose)
remarks on anticholinergics
Anticholinergics affect large, central airways, whereas B-adrenergic drugs dilate smaller airways
Use an aerosolized ipratropium bromide solution, 0.5 mg, in ED patients with mod-to-severe exacerbation
may decrease rate of hospitalization of mod-to-severe asthma
remarks on mechanical ventilation in asthma
mechanical ventilation does not relieve the airflow obstruction - it merely reduces the work of breathing and enables the patient to rest while the airflow obstruction is resolved
strategy to reduce air trapping in mechanical ventilation
using rapid inspiratory flow rates at a reduced respiratory frequency (12-14 breaths/min)
- allows adequate time for the expiratory phase
also, it is reasonable to target adequate arterial oxygen saturation (≥90%) without concern for “normalizing” the hypercarbic acidosis. This approach is called controlled mechanical hypoventilation or permissive hypoventilation
other remarks on mechanical ventilation in asthma
Ventilation of patients with acute asthma requires sedation
Neuromuscular block agents may be required, but extended use may cause postextubation muscle weakness